Tryp Rapport Episode 108 - Processing a Terminal Diagnosis with Psychedelics
Feb 22, 2026
A personal journey into psychedelics after a serious autoimmune diagnosis. Intense accounts of DMT, ayahuasca purging, and a five‑gram mushroom ordeal. Practical safety talk on 5‑MeO, dosing, administration methods, and the need for sitters. Comparisons of LSD, 2C‑B, mescaline, ketamine, MDMA, and cannabis and how timing and techniques affect surrender.
AI Snips
Chapters
Books
Transcript
Episode notes
Late Life Psychedelic Initiation
- Kenny's psychedelic journey began in his 50s after receiving mushrooms from a friend and using them during a period of grieving and a terminal autoimmune diagnosis.
- He made tea from a gram, got minimal visuals, then jumped to vaping DMT shortly after, despite no prior drug use history.
Subbreakthrough DMT Sessions On A Vape
- Kenny describes his first DMT attempts: burned-plastic taste, rapid visual pixelation of bees, a minute-long intense experience and feeling like he was dying.
- Subsequent attempts included Tron-like visuals and an Upanishad-style woman telling him to drop expectations, yet he never achieved a full breakthrough due to lung limitations.
Lung Disease Limits Breakthrough Potential
- Kenny has done DMT seven or eight times but hasn't had a breakthrough because his autoimmune disease reduces lung capacity, making holding inhalations difficult.
- He smokes alone, lacks a scale early on, and struggles to inhale and hold enough for a full breakthrough.
